fluorodeoxyglucose f18 has been researched along with s 1033 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellan, E; Biasco, G; Boschi, S; Castelli, M; Castellucci, P; Di Battista, M; Fanti, S; Gnocchi, C; Landuzzi, L; Lollini, PL; Nanni, C; Nannini, M; Nicoletti, G; Pantaleo, MA; Quarta, C; Rubello, D | 1 |
| Banerjee, P; Kung, AL; Tseng, JC; Wang, Y | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and s 1033
| Article | Year |
|---|---|
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Enzyme Inhibitors; Everolimus; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Mice; Mice, Knockout; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiopharmaceuticals; Receptor, Platelet-Derived Growth Factor alpha; Sirolimus; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2010 |
Incongruity of imaging using fluorescent 2-DG conjugates compared to 18F-FDG in preclinical cancer models.
Topics: Animals; Deoxyglucose; Fluorescence; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imaging, Three-Dimensional; Luminescent Measurements; Mice; Mice, Nude; Microscopy, Confocal; Pyrimidines; Radionuclide Imaging; Spectroscopy, Near-Infrared; Xenograft Model Antitumor Assays | 2012 |